BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29758567)

  • 1. Synthesis and in vitro Evaluation of 2-heteroarylidene-1-tetralone Derivatives as Monoamine Oxidase Inhibitors.
    Amakali KT; Legoabe LJ; Petzer A; Petzer JP
    Drug Res (Stuttg); 2018 Dec; 68(12):687-695. PubMed ID: 29758567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Evaluation of 2-benzylidene-1-tetralone Derivatives for Monoamine Oxidase Inhibitory Activity.
    Amakali KT; Legoabe LJ; Petzer A; Petzer JP
    Cent Nerv Syst Agents Med Chem; 2018; 18(2):136-149. PubMed ID: 29714148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Heteroarylidene-1-indanone derivatives as inhibitors of monoamine oxidase.
    Nel MS; Petzer A; Petzer JP; Legoabe LJ
    Bioorg Chem; 2016 Dec; 69():20-28. PubMed ID: 27662218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Tetralone derivatives as inhibitors of monoamine oxidase.
    Legoabe LJ; Petzer A; Petzer JP
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2758-63. PubMed ID: 24794105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibition of catechol O-methyltransferase and monoamine oxidase by tetralone and indanone derivatives substituted with the nitrocatechol moiety.
    de Beer AD; Legoabe LJ; Petzer A; Petzer JP
    Bioorg Chem; 2021 Sep; 114():105130. PubMed ID: 34225162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Synthesis and Evaluation of C7-Substituted α-Tetralone Derivatives as Inhibitors of Monoamine Oxidase.
    Legoabe LJ; Petzer A; Petzer JP
    Chem Biol Drug Des; 2015 Oct; 86(4):895-904. PubMed ID: 25581511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation of 1-tetralone and 4-chromanone derivatives as inhibitors of monoamine oxidase.
    Cloete SJ; N'Da CI; Legoabe LJ; Petzer A; Petzer JP
    Mol Divers; 2021 Feb; 25(1):491-507. PubMed ID: 32970293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indanones as high-potency reversible inhibitors of monoamine oxidase.
    Mostert S; Petzer A; Petzer JP
    ChemMedChem; 2015 May; 10(5):862-73. PubMed ID: 25820651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Benzylidene-1-indanone derivatives as inhibitors of monoamine oxidase.
    Nel MS; Petzer A; Petzer JP; Legoabe LJ
    Bioorg Med Chem Lett; 2016 Oct; 26(19):4599-4605. PubMed ID: 27578245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine oxidase inhibitory activities of heterocyclic chalcones.
    Minders C; Petzer JP; Petzer A; Lourens AC
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5270-6. PubMed ID: 26432037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Coumaranone derivatives as inhibitors of monoamine oxidase.
    Van Dyk AS; Petzer JP; Petzer A; Legoabe LJ
    Drug Des Devel Ther; 2015; 9():5479-89. PubMed ID: 26491258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthesis and evaluation of sesamol and benzodioxane derivatives as inhibitors of monoamine oxidase.
    Engelbrecht I; Petzer JP; Petzer A
    Bioorg Med Chem Lett; 2015 May; 25(9):1896-900. PubMed ID: 25857942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imidazole bearing chalcones as a new class of monoamine oxidase inhibitors.
    Sasidharan R; Baek SC; Sreedharannair Leelabaiamma M; Kim H; Mathew B
    Biomed Pharmacother; 2018 Oct; 106():8-13. PubMed ID: 29940538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of nitrocatechol chalcone and pyrazoline derivatives as inhibitors of catechol-O-methyltransferase and monoamine oxidase.
    Hitge R; Smit S; Petzer A; Petzer JP
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127188. PubMed ID: 32299731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and CYP24A1 inhibitory activity of (E)-2-(2-substituted benzylidene)- and 2-(2-substituted benzyl)-6-methoxy-tetralones.
    Aboraia AS; Makowski B; Bahja A; Prosser D; Brancale A; Jones G; Simons C
    Eur J Med Chem; 2010 Oct; 45(10):4427-34. PubMed ID: 20655626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel monoamine oxidase inhibitors based on the privileged 2-imidazoline molecular framework.
    Shetnev A; Osipyan A; Baykov S; Sapegin A; Chirkova Z; Korsakov M; Petzer A; Engelbrecht I; Petzer JP
    Bioorg Med Chem Lett; 2019 Jan; 29(1):40-46. PubMed ID: 30455149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine oxidase inhibitors: benzylidene-prop-2-ynyl-amines analogues.
    Jia Z; Wei S; Zhu Q
    Biol Pharm Bull; 2010; 33(4):725-8. PubMed ID: 20410615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of 1,4-benzoquinones as inhibitors of human monoamine oxidase.
    Mostert S; Petzer A; Petzer JP
    Eur J Med Chem; 2017 Jul; 135():196-203. PubMed ID: 28456030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors.
    Legoabe LJ; Petzer A; Petzer JP
    Drug Des Devel Ther; 2015; 9():3635-44. PubMed ID: 26203229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent and highly selective dual-targeting monoamine oxidase-B inhibitors: Fluorinated chalcones of morpholine versus imidazole.
    Mathew B; Baek SC; Thomas Parambi DG; Lee JP; Mathew GE; Jayanthi S; Vinod D; Rapheal C; Devikrishna V; Kondarath SS; Uddin MS; Kim H
    Arch Pharm (Weinheim); 2019 Apr; 352(4):e1800309. PubMed ID: 30663112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.